Skip to main content
OpenTrials
Completed

NCT Number: NCT02993718

Sedation by Dexmedetomidine and Propofol

Under the hypothesis that dexmedetomidine sedation would result in less upper airway obstruction, we evaluated the occurrence of upper airway collapse or the requirement of airway intervention in patients with obstructive sleep apnea during dexmedetomidine or propofol sedation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Surgery under spinal anesthesia
  • Intraoperative sedation
  • American Society of Anesthesiology physical status 1 or 2
  • Apnea/hypopnea index 5-14/h in Watch-PAT 200 analysis

Exclusion criteria

  • Anatomical defects on upper respiratory tract
  • Psychotic disorder
  • Drug addition
  • Alcohol addition
  • body mass index ≥ 35 kg/m2

Treatment and study plan

Dexmedetomidine

Drug

As a loading dose, 0.5 μg/kg dexmedetomidine was administered over 10 min, which was then administered continuously at a dose of 0.2-0.8 μg/kg/h. Sedation was maintained at modified observer's assessment of alertness/sedation scale 3

Propofol

Drug

Propofol was infused continuously via a target-controlled infusion device, and the effect-site concentration was maintained with a range of 0.5-2.0 μg/ml. Sedation was maintained at modified observer's assessment of alertness/sedation scale 3

Primary outcomes

  1. The occurrence of upper airway obstruction

    Time frame: During the sedation period, an average of 3 hours.

    When end-tidal carbon dioxide was not detected in spite of the respiratory effort during the sedation period, the case will be regarded as the occurrence of upper airway obstruction.

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Comparison of the Upper Airway Patency by Dexmedetomidine and Propofol Used for Sedation

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Dec 15, 2016
Registry last updated
Sep 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.